|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.00 JPY | -1.32% |
|
-9.64% | -55.36% |
| 05-15 | Monstarlab Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 01-05 | Monster Labor Board OKs Investment in Singapore-Based Fund | MT |
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | -20.57 | -2.13 | -13.67 | -30.31 | 4.43 | |
Return on Total Capital | -28.37 | -3.06 | -18.96 | -42.92 | 6.44 | |
Return On Equity % | -95.37 | -19.5 | -59.49 | 1.87K | 17.38 | |
Return on Common Equity | -88.33 | -16.17 | -56.78 | 1.94K | 21 | |
Margin Analysis | ||||||
Gross Profit Margin % | 31.33 | 34.65 | 25.03 | 14.25 | 40.4 | |
SG&A Margin | 45.42 | 39.43 | 45.96 | 50.95 | 32.48 | |
EBITDA Margin % | - | - | -19.17 | -50.08 | 9.52 | |
EBITA Margin % | -34.49 | -2.73 | -22.44 | -53.44 | 7.65 | |
EBIT Margin % | -34.49 | -2.73 | -22.44 | -53.44 | 7.65 | |
Income From Continuing Operations Margin % | -33.04 | -5.06 | -17.38 | -99.75 | -4.59 | |
Net Income Margin % | -32.67 | -4.72 | -17.65 | -99.44 | -4.32 | |
Net Avail. For Common Margin % | -32.67 | -4.72 | -17.65 | -99.44 | -5.44 | |
Normalized Net Income Margin | -20.28 | -1.62 | -14.68 | -30.44 | 4.05 | |
Levered Free Cash Flow Margin | - | - | -9.44 | -10.86 | -3.52 | |
Unlevered Free Cash Flow Margin | - | - | -9.01 | -9.85 | -2.39 | |
Asset Turnover | ||||||
Asset Turnover | 0.95 | 1.25 | 0.97 | 0.91 | 0.93 | |
Fixed Assets Turnover | 18.94 | 29 | 21.05 | 23.76 | 42.14 | |
Receivables Turnover (Average Receivables) | 5.63 | 5.71 | 4.71 | 6 | 9.19 | |
Inventory Turnover (Average Inventory) | 2.57K | - | - | 268.06 | - | |
Short Term Liquidity | ||||||
Current Ratio | 1.93 | 1.43 | 0.74 | 0.48 | 2.33 | |
Quick Ratio | 1.65 | 1.06 | 0.55 | 0.4 | 2.03 | |
Operating Cash Flow to Current Liabilities | - | - | -0.44 | -0.54 | -0.06 | |
Days Sales Outstanding (Average Receivables) | 64.89 | 63.93 | 77.58 | 60.98 | 39.73 | |
Days Outstanding Inventory (Average Inventory) | 0.14 | - | - | 1.37 | - | |
Average Days Payable Outstanding | 65.94 | - | - | 39.21 | - | |
Cash Conversion Cycle (Average Days) | -0.91 | - | - | 23.13 | - | |
Long Term Solvency | ||||||
Total Debt/Equity | 109.36 | 119.03 | 190.91 | -200.29 | 932.27 | |
Total Debt / Total Capital | 52.24 | 54.34 | 65.62 | 199.71 | 90.31 | |
LT Debt/Equity | 77.92 | 64.4 | 55.1 | -127.16 | 882.95 | |
Long-Term Debt / Total Capital | 37.22 | 29.4 | 18.94 | 126.78 | 85.54 | |
Total Liabilities / Total Assets | 66.59 | 68.32 | 74.37 | 162.93 | 92.87 | |
EBIT / Interest Expense | -42.97 | -2.99 | -32.55 | -33.2 | 4.23 | |
EBITDA / Interest Expense | - | - | -27.82 | -31.12 | 5.26 | |
(EBITDA - Capex) / Interest Expense | - | - | -29.13 | -31.39 | 5.14 | |
Total Debt / EBITDA | - | - | -2.76 | -1.91 | 8.25 | |
Net Debt / EBITDA | - | - | -2.07 | -1.6 | 2.92 | |
Total Debt / (EBITDA - Capex) | - | - | -2.64 | -1.89 | 8.45 | |
Net Debt / (EBITDA - Capex) | - | - | -1.97 | -1.59 | 2.99 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | 25.97 | 52.69 | -6.48 | -25.05 | -22.07 | |
Gross Profit, 1 Yr. Growth % | 36.38 | 68.85 | -32.44 | -57.34 | 120.98 | |
EBITDA, 1 Yr. Growth % | - | - | - | 95.78 | -114.81 | |
EBITA, 1 Yr. Growth % | 114.58 | -87.93 | 669.92 | 78.5 | -111.15 | |
EBIT, 1 Yr. Growth % | 114.58 | -87.93 | 669.92 | 78.5 | -111.15 | |
Earnings From Cont. Operations, 1 Yr. Growth % | 109.78 | -76.62 | 221.33 | 330.09 | -96.41 | |
Net Income, 1 Yr. Growth % | 139.64 | -77.92 | 249.41 | 322.38 | -96.61 | |
Normalized Net Income, 1 Yr. Growth % | 146.34 | -87.83 | 748.86 | 55.44 | -110.38 | |
Diluted EPS Before Extra, 1 Yr. Growth % | 102.55 | -78.34 | 185.91 | 306.88 | -97.38 | |
Accounts Receivable, 1 Yr. Growth % | 37.87 | 59.55 | -15.39 | -71.81 | 31.51 | |
Inventory, 1 Yr. Growth % | 300 | - | - | -93.33 | - | |
Net Property, Plant and Equip., 1 Yr. Growth % | -49.54 | 97.28 | -5.82 | -63.09 | -37 | |
Total Assets, 1 Yr. Growth % | 2.43 | 30.4 | 11.92 | -47.52 | 21.36 | |
Tangible Book Value, 1 Yr. Growth % | 330.77 | -57.09 | -217.56 | 531.97 | -96.85 | |
Common Equity, 1 Yr. Growth % | 18.7 | 22.17 | -19.04 | -227.67 | -114.77 | |
Cash From Operations, 1 Yr. Growth % | - | - | - | -12.28 | -95.24 | |
Capital Expenditures, 1 Yr. Growth % | - | - | - | -63.64 | -61.36 | |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | - | -13.78 | -74.71 | |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | - | -18.02 | -81.07 | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | 38.69 | 19.5 | -16.28 | -23.58 | |
Gross Profit, 2 Yr. CAGR % | - | 51.75 | 6.8 | -46.31 | -2.9 | |
EBITDA, 2 Yr. CAGR % | - | - | - | - | -46.15 | |
EBITA, 2 Yr. CAGR % | - | -49.11 | -3.6 | 270.71 | -55.39 | |
EBIT, 2 Yr. CAGR % | - | -49.11 | -3.6 | 270.71 | -55.39 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | -29.97 | -13.32 | 271.75 | -60.72 | |
Net Income, 2 Yr. CAGR % | - | -27.26 | -12.17 | 284.16 | -62.17 | |
Normalized Net Income, 2 Yr. CAGR % | - | -45.24 | 1.65 | 263.24 | -59.83 | |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | -33.77 | -21.31 | 241.07 | -67.33 | |
Accounts Receivable, 2 Yr. CAGR % | - | 48.31 | 16.19 | -51.16 | -39.11 | |
Inventory, 2 Yr. CAGR % | - | - | 287.3 | - | - | |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | -0.23 | 36.31 | -41.04 | -51.78 | |
Total Assets, 2 Yr. CAGR % | - | 15.57 | 20.8 | -23.36 | -20.19 | |
Tangible Book Value, 2 Yr. CAGR % | - | 35.96 | -28.97 | 172.56 | -55.38 | |
Common Equity, 2 Yr. CAGR % | - | 20.42 | -0.55 | 1.67 | -56.57 | |
Cash From Operations, 2 Yr. CAGR % | - | - | - | - | -79.56 | |
Capital Expenditures, 2 Yr. CAGR % | - | - | - | - | -62.52 | |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | - | -53.3 | |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | - | -60.61 | |
Compound Annual Growth Rate Over Three Years | ||||||
Total Revenues, 3 Yr. CAGR % | - | - | 21.62 | 2.29 | -18.25 | |
Gross Profit, 3 Yr. CAGR % | - | - | 15.87 | -21.34 | -13.96 | |
EBITA, 3 Yr. CAGR % | - | - | 25.87 | 18.37 | 15.28 | |
EBIT, 3 Yr. CAGR % | - | - | 25.87 | 18.37 | 15.28 | |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | 16.38 | 47.84 | -20.85 | |
Net Income, 3 Yr. CAGR % | - | - | 22.73 | 48.25 | -20.63 | |
Normalized Net Income, 3 Yr. CAGR % | - | - | 36.54 | 17.11 | 11.05 | |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | 7.84 | 36.07 | -32.67 | |
Accounts Receivable, 3 Yr. CAGR % | - | - | 23.01 | -27.53 | -32.05 | |
Inventory, 3 Yr. CAGR % | - | - | 291.49 | 0 | - | |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | -2.13 | -11.81 | -39.72 | |
Total Assets, 3 Yr. CAGR % | - | - | 14.34 | -8.51 | -10.67 | |
Tangible Book Value, 3 Yr. CAGR % | - | - | 29.53 | 47.18 | -38.37 | |
Common Equity, 3 Yr. CAGR % | - | - | 5.49 | 8.09 | -46.55 | |
Compound Annual Growth Rate Over Five Years | ||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | - | 0.99 | |
Gross Profit, 5 Yr. CAGR % | - | - | - | - | 7.96 | |
EBITA, 5 Yr. CAGR % | - | - | - | - | -16.88 | |
EBIT, 5 Yr. CAGR % | - | - | - | - | -16.88 | |
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | - | -24.63 | |
Net Income, 5 Yr. CAGR % | - | - | - | - | -23.35 | |
Normalized Net Income, 5 Yr. CAGR % | - | - | - | - | -16.31 | |
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | - | -33.11 | |
Accounts Receivable, 5 Yr. CAGR % | - | - | - | - | -7.15 | |
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | - | -26.26 | |
Total Assets, 5 Yr. CAGR % | - | - | - | - | -0.98 | |
Tangible Book Value, 5 Yr. CAGR % | - | - | - | - | -15.43 | |
Common Equity, 5 Yr. CAGR % | - | - | - | - | -26.03 |
- Stock Market
- Stocks
- 5255 Stock
- Financials Monstarlab Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















